MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Creightons incurs £4.5 million impairment for Emma Hardie business

ALN

Creightons PLC shares fell on Monday, after it said it faces an impairment charge that will have a material adverse impact on its full-year profit.

The Peterborough, England-based company is a product developer and brand owner operating in the personal care, beauty, and fragrance sectors.

Shares in Creightons were down 12% to 18.52 pence each in London on Monday morning.

In July 2021, Creightons purchased the skincare company Emma Hardie Ltd for a £6.2 million consideration.

Today, ahead of the company’s annual results for the year ending March 31, Creightons said that following a review of the brand it will face an exceptional impairment charge of around £4.5 million.

This impairment will also result in a de-recognition of the goodwill value of £1.3 million relating to the deferred tax, with consequential adjustments to the deferred tax accrual. The net effect of these will be a tax charge of approximately £170,000.

The net impact on accounts will be a £4.6 million non-cash post-tax charge.

Consequentially, despite reporting improved profit and cash generation in the second half of the year, full-year profit will be impacted by the aforementioned charge.

Results for the year are due to be published on July 18.

Copyright 2024 Alliance News Ltd. All Rights Reserved.